← Back to Analyst Consensus 
URGN Buy
UroGen Pharma Ltd.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Aug 6, 2026 | Guggenheim | maintain | Buy → Buy | $58 | 52% |
| Aug 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $75 | 44% |
| Aug 5, 2026 | TD Cowen | maintain | Buy → Buy | $60 | 54% |
| Jul 21, 2026 | Guggenheim | maintain | Buy → Buy | $42 | 52% |
| Jul 16, 2026 | Oppenheimer | maintain | Outperform → Outperformer | $50 | 52% |
| Jun 3, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| May 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| May 11, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| May 7, 2026 | Oppenheimer | maintain | Outperform → Outperform | $40 | 52% |
| Mar 31, 2026 | D. Boral Capital | maintain | Buy → Buy | $33 | 34% |
| Mar 2, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Jan 23, 2026 | D. Boral Capital | maintain | Buy → Buy | $33 | 34% |
| Jan 5, 2026 | D. Boral Capital | maintain | Buy → Buy | $33 | 34% |
| Oct 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Oct 27, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Oct 3, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Aug 19, 2025 | Piper Sandler | initiate | — → Overweight | $36 | 54% |
| Aug 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Aug 7, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Aug 5, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Jul 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Jul 7, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Jun 16, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $50 | 44% |
| Jun 13, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $47 | 55% |
| Jun 13, 2025 | Guggenheim | maintain | Buy → Buy | $30 | 52% |
| Jun 13, 2025 | Oppenheimer | maintain | Outperform → Outperform | $31 | 52% |
| Jun 12, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Jun 3, 2025 | Oppenheimer | maintain | Outperform → Outperform | $10 | 52% |
| May 23, 2025 | Guggenheim | maintain | Buy → Buy | $15 | 52% |
| May 22, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $3 | 54% |
| May 22, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| May 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| May 12, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| May 8, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Apr 29, 2025 | Guggenheim | reiterate | Buy → Buy | $40 | 52% |
| Apr 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Apr 28, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Apr 17, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $16 | 54% |
| Apr 16, 2025 | Scotiabank | initiate | — → Sector Outperform | $23 | 55% |
| Mar 13, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Mar 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $55 | 44% |
| Mar 10, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Feb 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $64 | 44% |
| Feb 20, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Feb 18, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Feb 12, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Jan 23, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Jan 15, 2025 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
| Dec 6, 2024 | D. Boral Capital | maintain | Buy → Buy | $25 | 34% |
Price Target Trend
May 5, 2026 Latest: $60 Oct 26, 2026
EPS Estimates
+1y $2.59
Lo: $1.05 Hi: $5.19
7 analysts ▲5
0y $-0.24
Lo: $-0.83 Hi: $0.20
7 analysts ▲5
0q $0.09
Lo: $-0.07 Hi: $0.19
7 analysts ▲5
+1q $0.39
Lo: $-0.01 Hi: $0.77
7 analysts ▲5
Cross-Platform Signals
No cross-platform signals in the last 90 days